Hangzhou Tigermed Consulting Dividend
Dividend criteria checks 5/6
Hangzhou Tigermed Consulting is a dividend paying company with a current yield of 0.96% that is well covered by earnings.
Key information
1.0%
Dividend yield
29%
Payout ratio
Industry average yield | 1.5% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | CN¥1.96 |
Dividend yield forecast in 3Y | 1.0% |
Recent dividend updates
Recent updates
Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 28Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Apr 08Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues
Apr 04Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models
Apr 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300347's dividends per share have been stable in the past 10 years.
Growing Dividend: 300347's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Hangzhou Tigermed Consulting Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (300347) | 1.0% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.4% |
Industry Average (Life Sciences) | 1.5% |
Analyst forecast in 3 Years (300347) | 1.0% |
Notable Dividend: 300347's dividend (0.96%) is higher than the bottom 25% of dividend payers in the CN market (0.65%).
High Dividend: 300347's dividend (0.96%) is low compared to the top 25% of dividend payers in the CN market (2.35%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (29.1%), 300347's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (53.1%), 300347's dividend payments are covered by cash flows.